Milestone Pharmaceuticals (MIST)
(Delayed Data from NSDQ)
$1.92 USD
-0.03 (-1.54%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.92 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Milestone Pharmaceuticals Inc. has a market cap of $165.74M, which represents its share price of $1.95 multiplied by its outstanding shares number of 84.99M. As a small-cap company, MIST's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
MIST 1.92 -0.03(-1.54%)
Will MIST be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MIST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MIST
Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's Why
MIST Stock Falls 66% Following Complete Response Letter for Cardamyst
MIST: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Golden Cross, Milestone Pharmaceuticals (MIST)'s Technical Outlook is Bright
Other News for MIST
Is MIST coiling for a breakout? NR7 shows up after advancing 0.52%
MIST forms Upper Bollinger Band Walk on September 17
MIST forms Death Cross on September 16
Is MIST signaling a buying opportunity? New Uptrend shows up after advancing 0.51%
Analysts Offer Insights on Healthcare Companies: Kala Pharmaceuticals (KALA) and Milestone Pharmaceuticals (MIST)